Neuroplasticity/neurodegeneration phenotypic aging

1 paper1 finding

Humans1

Associations

1

Proton-pump inhibitors

downin humans1

1 study

Proton-pump inhibitors are associated with neuroplasticity/neurodegeneration phenotypic aging in humans (β = -1.00, 95% CI -2.02 to -0.03).
“neuroplasticity/neurodegeneration (Beta = -1.00, 95% CI: -2.02 to -0.03), respectively.”
Humans
Longitudinal associations between medication use and phenotypic aging: insights from the Baltimore longitudinal study of aging
The journals of gerontology. Series A, Biological sciences and medical sciences11 Jun 2025

More on Proton-pump inhibitors

Latest

The Journals of Gerontology, Series A11 Jun

Longitudinal associations between medication use and phenotypic aging: insights from the Baltimore longitudinal study of aging

Cohort study in peoplePopulations